Nuvalent Ownership | Who Owns Nuvalent?
Nuvalent Ownership Summary
Nuvalent is owned by 107.37% institutional investors, 3.12% insiders. Deerfield management company, l.p. (series c) is the largest institutional shareholder, holding 27.39% of NUVL shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 3.52% of its assets in Nuvalent shares.
NUVL Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Nuvalent | 107.37% | 3.12% | -10.50% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Deerfield management company, l.p. (series c) | 17.99M | 27.39% | $1.41B |
Fmr | 9.65M | 14.70% | $755.74M |
Paradigm biocapital advisors lp | 5.36M | 8.17% | $419.85M |
Vanguard group | 4.50M | 6.85% | $352.25M |
Blackrock funding, inc. /de | 3.85M | 5.86% | $301.50M |
Blackrock | 3.02M | 4.71% | $229.37M |
Perceptive advisors | 2.62M | 3.99% | $205.09M |
Commodore capital lp | 1.62M | 2.47% | $126.94M |
Bain capital life sciences investors | 1.45M | 2.20% | $113.29M |
State street | 1.33M | 2.07% | $100.59M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Deerfield management company, l.p. (series c) | 17.99M | 26.67% | $1.41B |
Paradigm biocapital advisors lp | 5.36M | 14.61% | $419.85M |
Bain capital life sciences investors | 1.45M | 13.33% | $113.29M |
Fairmount funds management | 1.32M | 10.25% | $103.15M |
Commodore capital lp | 1.62M | 9.30% | $126.94M |
Silverarc capital management | 400.01K | 6.85% | $31.31M |
Artia global partners lp | 204.04K | 5.71% | $15.97M |
Perceptive advisors | 2.62M | 5.65% | $205.09M |
Boxer capital | 1.12M | 4.48% | $84.98M |
First turn management | 309.52K | 4.34% | $24.23M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Commodore capital lp | 1.62M | 9.30% | 681.60K |
Vestal point capital, lp | 600.00K | 2.78% | 600.00K |
Adage capital partners gp | 680.00K | 0.09% | 400.00K |
Vanguard group | 4.50M | 0.01% | 366.24K |
Paradigm biocapital advisors lp | 5.36M | 14.61% | 363.38K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Deerfield management company, l.p. (series c) | 17.99M | 26.67% | -2.00M |
Darwin global management | - | - | -1.44M |
Bain capital life sciences investors | 1.45M | 13.33% | -1.25M |
Fairmount funds management | 1.32M | 10.25% | -369.40K |
Perceptive advisors | 2.62M | 5.65% | -359.26K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Vestal point capital, lp | 600.00K | 2.78% | 600.00K | $46.97M |
Norges bank | 318.74K | 0.00% | 318.74K | $24.95M |
Polar capital | 287.50K | 0.13% | 287.50K | $21.81M |
Braidwell lp | 241.24K | 0.56% | 241.24K | $18.88M |
American century companies | 186.38K | 0.01% | 186.38K | $14.59M |
Sold Out
Holder | Change |
---|---|
Financial gravity asset management | -1.00 |
Massmutual trust co fsb/adv | -8.00 |
Lynx investment advisory | -15.00 |
Nelson, van denburg & campbell wealth management group | -16.00 |
Continuum advisory | -28.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 226 | 8.65% | 70,521,617 | 0.93% | 107 | 0.95% | 142 | 17.36% | 49 | -10.91% |
Sep 30, 2024 | 208 | 16.85% | 69,868,503 | 6.54% | 106 | 1.02% | 122 | 24.49% | 54 | - |
Jun 30, 2024 | 178 | -3.78% | 65,581,790 | 3.58% | 102 | 1.05% | 98 | -8.41% | 54 | -6.90% |
Mar 31, 2024 | 185 | 9.47% | 63,315,326 | -0.47% | 98 | 0.83% | 107 | -10.83% | 58 | 141.67% |
Dec 31, 2023 | 169 | 36.29% | 63,616,717 | 13.92% | 109 | 1.14% | 120 | 71.43% | 24 | -22.58% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Growth Compy Commingled Pl O | 2.49M | 3.52% | - |
Fidelity Growth Compy Commingled Pl S | 2.41M | 3.37% | -334.72K |
Fidelity Growth Company Fund | 1.75M | 2.45% | -80.00K |
Vanguard Total Stock Mkt Idx Inv | 1.47M | 2.05% | 1.08K |
Vanguard Small Cap Index | 1.17M | 1.64% | 989.00 |
iShares Russell 2000 ETF | 927.16K | 1.29% | -8.03K |
Vanguard Small Cap Value Index Inv | 772.44K | 1.08% | -2.56K |
Fidelity Select Health Care | 670.00K | 0.94% | - |
SPDR® S&P Biotech ETF | 627.16K | 0.88% | -6.72K |
Vanguard Institutional Extnd Mkt Idx Tr | 584.78K | 0.82% | 848.00 |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Mar 27, 2025 | Noci Darlene | Chief Development Officer | Sell | $66.45K |
Mar 27, 2025 | Noci Darlene | Chief Development Officer | Sell | $226.02K |
Mar 17, 2025 | Porter James Richard | President and CEO | Sell | $755.61K |
Mar 17, 2025 | Porter James Richard | President and CEO | Sell | $1.25M |
Mar 17, 2025 | Porter James Richard | President and CEO | Sell | $46.09K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | 41 |
2024 Q4 | - | 33 |
2024 Q3 | - | 73 |
2024 Q2 | - | 51 |
2024 Q1 | - | 17 |
NUVL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools